Zomarist vildagliptin/metformin regulatory update

Germany's Institute for Quality and Efficiency in Healthcare (IQWiG) issued a preliminary benefit assessment for Zomarist vildagliptin/metformin from Novartis saying that the Type II diabetes drug has...